Skip to main content
Clinical Trials/ISRCTN13293865
ISRCTN13293865Completed未知

PHOSP-COVID - Rehabilitation for lasting symptoms of COVID-19

niversity of Leicester0 sites186 target enrollmentStarted: July 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
186

Study Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36703183/ (added 27/01/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Ongoing symptoms following COVID-19 infection that are deemed modifiable by a rehabilitation programme
  • 2. Hospitalisation during an acute infection of COVID-19

Exclusion Criteria

  • 1. Unwilling to consent for the trial
  • 2. Full recovery of symptoms reported by the patient (physical and psychological)
  • 3. Persistent symptoms indicative of other significant medical conditions that require further investigation/management
  • 4. Currently on or recently completed a course of COVID rehabilitation (previous 6 months)
  • 5. Contraindications for exercise (American College of Sports Medicine)

Investigators

Sponsor
niversity of Leicester

Similar Trials